Next Article in Journal
Editors Note
Previous Article in Journal
Interstitial Pneumonia with Autoimmune Features (IPAF) and Radiological Findings Suggestive of Lymphocytic Interstitial Pneumonia (LIP)—Case Report
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
ARM
Volume 85
Issue 1
10.5603/ARM.2017.0010
arm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Tropical Pulmonary Eosinophilia: Effect of Addition of Corticosteroids after Failure of Diethylcarbamazine Therapy

by
Manu Madan
,
Pawan Gupta
,
Richa Mittal
and
Sunil K. Chhabra
*
Department of Pulmonary Medicine, Vallabhbhai Patel Chest Institute, University of Delhi, New Delhi, India
*
Author to whom correspondence should be addressed.
Adv. Respir. Med. 2017, 85(1), 51-54; https://doi.org/10.5603/ARM.2017.0010
Submission received: 13 August 2016 / Revised: 13 February 2017 / Accepted: 13 February 2017 / Published: 13 February 2017

Abstract

Successful response in diethylcarbamazine (DEC) therapy in tropical pulmonary eosinophilia (TPE) is not universal with a 20–40% failure rates in chronic cases. Corticosteroids have been used in such patients. However, their role in management remains ill-defined. A patient of TPE with incomplete clinical, haematological and physiological response to a standard 3 weeks DEC therapy received additional corticosteroids for the next two cycles, after which complete remission occurred. However, there was a relapse two months later with evidence of a chronic state requiring further treatment with corticosteroids with good response.
Keywords: tropical pulmonary eosinophilia; diethylcarbamazine; corticosteroids tropical pulmonary eosinophilia; diethylcarbamazine; corticosteroids

Share and Cite

MDPI and ACS Style

Madan, M.; Gupta, P.; Mittal, R.; Chhabra, S.K. Tropical Pulmonary Eosinophilia: Effect of Addition of Corticosteroids after Failure of Diethylcarbamazine Therapy. Adv. Respir. Med. 2017, 85, 51-54. https://doi.org/10.5603/ARM.2017.0010

AMA Style

Madan M, Gupta P, Mittal R, Chhabra SK. Tropical Pulmonary Eosinophilia: Effect of Addition of Corticosteroids after Failure of Diethylcarbamazine Therapy. Advances in Respiratory Medicine. 2017; 85(1):51-54. https://doi.org/10.5603/ARM.2017.0010

Chicago/Turabian Style

Madan, Manu, Pawan Gupta, Richa Mittal, and Sunil K. Chhabra. 2017. "Tropical Pulmonary Eosinophilia: Effect of Addition of Corticosteroids after Failure of Diethylcarbamazine Therapy" Advances in Respiratory Medicine 85, no. 1: 51-54. https://doi.org/10.5603/ARM.2017.0010

APA Style

Madan, M., Gupta, P., Mittal, R., & Chhabra, S. K. (2017). Tropical Pulmonary Eosinophilia: Effect of Addition of Corticosteroids after Failure of Diethylcarbamazine Therapy. Advances in Respiratory Medicine, 85(1), 51-54. https://doi.org/10.5603/ARM.2017.0010

Article Metrics

Back to TopTop